Atlas Trials

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Clinical trial NCT03029585 · TERMINATED

Trial details

NCT number
NCT03029585
Sponsor
NanOlogy, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Carcinoma
Start date
2017-04-19
Primary completion
2019-11-04
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.